T1	Participants 244 305	patients admitted for the first MI with recurrent MI patients
T2	Participants 560 630	patients enrolled in the Beta-Blocker in Heart Attack Trial (n = 2830)
T3	Participants 645 713	Forty-three variables (including in-hospital and post-hospital data)
T4	Participants 765 831	Ten variables were independently associated with 1-year mortality:
